bs-10660R-PerCP-Cy5.5 Search Results


antibodies against drd1  (Bioss)
90
Bioss antibodies against drd1
Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated <t>dopamine</t> <t>D1</t> <t>receptors</t> ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group
Antibodies Against Drd1, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against drd1/product/Bioss
Average 90 stars, based on 1 article reviews
antibodies against drd1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
scp3 polyclonal antibody, percp-cy5.5 conjugated  (Bioss)
N/A
This gene encodes an essential structural component of the synaptonemal complex. This complex is involved in synapsis, recombination and segregation of meiotic chromosomes. Mutations in this gene are associated with azoospermia in males and susceptibility
   Buy from Supplier

Image Search Results


Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated dopamine D1 receptors ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group

Journal: Acta Pharmacologica Sinica

Article Title: Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway

doi: 10.1038/s41401-019-0296-7

Figure Lengend Snippet: Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated dopamine D1 receptors ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group

Article Snippet: Antibodies against DRD1 and DRD2 were obtained from Bioss (Beijing, China).

Techniques: